Thank you. I'd now like to hand over to our first speaker for today, Julianna Paterra, Vice President of Investor Relations. You may now begin.
Thank you, and good morning, everyone. Welcome to Verano's third quarter 2024 earnings conference call. I am joined today by George Archos, Founder and Chief Executive Officer, Brett Summerer, Chief Financial Officer, Darren Weiss, President, and Aaron Miles, Chief Investment Officer. During this call, we will discuss our business outlook and make forward-looking statements within the meaning of applicable U.S. and Canadian securities laws, which are based on management's current assumptions and expectations. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results, performance, and achievements of the business or developments in the company's industry to differ materially from those implied by such forward-looking statements. Actual events or results could differ considerably due to risks and uncertainties mentioned in our filings on EDGAR and SEDAR, including our financial statements for the quarter ended September 30, 2024.
In addition, throughout today's discussion, we will refer to non-GAAP financial measures that do not have any standardized meaning prescribed by GAAP. Management believes non-GAAP results are useful to enhance the understanding of the company's ongoing performance, but these are supplemental to and should not be considered in isolation from or as a substitute for GAAP financial measures. These non-GAAP measures are defined in our earnings press release and available on our website at investors.verano.com, which also includes the reconciliation of these measures to the respective most directly comparable GAAP financial measures. Lastly, all currencies in U.S. dollars unless otherwise noted. I'll now pass it to George.
Welcome, and thank you all for joining this morning. It's been an exciting week for the cannabis industry and our nation. Although we'll talk about third quarter performance for some of our key markets, we will begin this morning by diving into the impacts of Tuesday's historic election. As you all know, a majority of Floridians came out to the polls on Tuesday and voted in favor of safe, legal access to cannabis. Almost 56% of voters said yes to adult use, a higher percentage of voters than approved adult use sales in California when they legalized. Almost as many Floridians expressed their support for adult use cannabis as voted for President-elect Donald Trump. Unfortunately, the 60% approval threshold was just too high to overcome.
We are, however, deeply encouraged that a strong majority still said yes and believe we will still see an adult use program for Florida sometime in the future as its residents come to fully understand the negative impacts of an unregulated and untaxed illicit market. We remain committed to the Florida medical market and, as we've discussed on previous calls this year, have been busy expanding capacity in the state irrespective of adult use. And while our Apollo Beach facility's enhancements were needed to help us better serve the medical demands of today in Florida, we didn't feel expansion of that facility alone was enough to meet the growing medical demands of tomorrow.
So back in the summer, we embarked onto our third Florida cultivation facility in Ocala, which will be a world-class cultivation and production facility built leveraging our years of operational expertise to improve efficiencies, streamline distribution, reduce production costs, and increase profitability in the Sunshine State. And while the vote didn't go in our favor Tuesday night, we are proud of the investments we've made in such a profitable medical market and are confident we will realize a strong return on these investments. These efficiencies will allow us to more strongly compete on price point with our top-tier products. Additionally, Ocala is a large facility that provides optionality to scale up commensurate with market growth. And though had Florida passed Amendment 3, we would have had another growth catalyst behind us. We've always built our business to thrive in the current environment with a focus on margin preservation.
While the last few months we've been focused on Florida, we are returning full focus to margins and cost management. Moving forward, we will be fully engaged in evaluating efficiency improvements and cost-cutting measures across the business. As you've seen from recent OMMU volume data, we have been steadily growing market share over the past few weeks, reflecting the increased output we began to see late September from our Apollo facility. Our share of both milligrams of THC and ounces of flower surged in October to the number two spot, our highest volume share year to date. Returning to the election, I think it's important to recognize that this was the first presidential cycle in history where we saw both candidates not only make cannabis a topic of national interest, but express their unequivocal support for liberalization of cannabis laws.
It was comforting knowing that either way the top of ticket turned out, we would have an administration supportive of the historic rescheduling process currently underway. A Schedule III classification brings a world of opportunity for Verano, the largest of which is a tax code similar to that of other corporations in the U.S., saving us what we estimate would be over $80 million annually based on our 2023 results. We continue to prep internally for a final Schedule III ruling so that we can readily capitalize on any and all opportunities at our disposal. We are excited to embark on a new partnership with the Trump administration to usher in a fresh era for legal cannabis while simultaneously edging out the dangers of the illicit market.
With the ALJ hearing likely scheduled for early next year, we are hopeful that the industry will have finality regarding a Schedule III decision sometime next year. President-elect Trump's pro-cannabis statements were a continuation of a growing trend of bipartisan support. In addition to supporting legal adult use sales, he has said, and I quote, "We will continue to focus on research to unlock medical uses of marijuana to a Schedule III drug and work with Congress to pass common-sense laws, including safe banking for state-authorized companies." We have been begging for common-sense laws for years, so we welcome this approach with open arms. Additionally, our read is that his administration will be friendly towards banking acts such as the SAFE or SAFER acts, which could not only expand our banking access but also reduce our cost of debt. The term Republican is no longer associated with anti-cannabis sentiment.
This is principally a generational issue, not left and right, and demographic trends are all moving in the direction of greater and greater support for common-sense cannabis laws. Additionally, this isn't the environment of eight years ago. Cannabis has come an incredibly long way with a majority of Americans in support of legal cannabis sales. We believe the progress from the last decade will continue and affect change and are pushing forward on a number of fronts, including our litigation against the government in our Commerce Clause case to ensure that progress continues. Moving on to other market updates, we continue to see increased competition from new retail openings in Illinois and New Jersey. This normalization in New Jersey has been stronger and more persistent than we had initially predicted a few quarters ago, with 25 new dispensaries opening in about the last three months alone.
Plus, we've seen 18 cultivators, largely small-scale craft growers, begin wholesaling year to date. The good news is that the velocity of our retail declines has significantly slowed, with the third quarter only down 4% sequentially. As the pace of new openings slows, we anticipate hitting an equilibrium in the next few quarters but are bracing for some additional short-term pressure. The expanding retail environment in Illinois, with 55 dispensaries opened year to date and 14 alone in the third quarter, has proven an opportunity for us on the wholesale side. Gross and net demand grew throughout the year, and net wholesale revenue increased by 10% year- over- year. Given this upward demand trend, largely in flower, we reopened rooms in our cultivation facility and increased production. We continue to view growing dispensary counts as wholesale opportunity and will maintain our focus on growing Verano's total shelf space in Illinois.
We were thrilled to close incredibly quickly, in under a month, on the Virginia and Arizona businesses from cannabis in August. The Virginia business is ripe with opportunity as we've begun launching our Verano products. With further enhancements and additions forthcoming to the business, all of which require very little CapEx, we look forward to bringing to market products Virginia has not seen before. Lastly, Ohio's adult use program had a modestly strong start, with August and September net retail revenue each up about two times versus July. On the wholesale side, we ramped up operations, selling into over 70% more doors and increasing net wholesale revenue by 2.5 x versus the prior year. Additionally, we increased our vertical mix by about 10%, up to 36% for the third quarter versus the prior year.
We anticipate opening our Antwerp location near the border of Indiana and the Fort Wayne metro area in the next few months, which we expect to benefit from some level of cannabis tourism, bringing our footprint to six dispensaries in the Buckeye State. We had a busy quarter, and I am very proud of our team for nimbly navigating changing retail landscapes, welcoming and integrating new lines of business, and responding in real time to hurricane risks and disruptions. Thank you all for your continued persistence. And now to Brett with the financials.
Thanks, George. Revenue for the quarter decreased versus the prior quarter to $217 million due to declines in Florida as demand exceeded our supply given construction in our Apollo facility, in addition to increased competition across Illinois and New Jersey. Specifically in Florida, we are very grateful that all employees and operations were unharmed by Hurricanes Helene and Milton. Helene ended up having a very minor impact on the top line due to limited retail closures, though, of course, created a period of depressed demand as communities rebuilt. Milton, however, had a much larger impact, with up to 56 dispensaries closed for a few days, with a tail of continued closures as the storm passed over the state. Additionally, Arizona's wholesale seasonality impact was much greater than we've typically seen as a heat wave hung over the state with 113 days in a row of 100+ degree heat.
On a gross revenue basis, excluding intersegment eliminations, 64.5% of sales were derived from the retail business, with the largest contributions from Florida, Illinois, and New Jersey. The remaining 35.5% of sales were derived from the wholesale side of the business, with the largest contributions from New Jersey, Illinois, and Connecticut. Regarding net or third-party wholesale revenue, as we saw accounts receivable continue to increase, we took an intentional step to pause on certain delinquent accounts, which represented a high single-digit percent impact to wholesale revenue. We are going to continue to evaluate our third-party wholesale customer relationships as a result. Gross profit for the quarter was $109 million, or 50% of revenue, versus $114 million, or 51% of revenue in the prior quarter. The sequential decrease in gross profit was driven by declines in revenue.
Looking ahead, we will be making inventory reduction efforts as part of cost savings and rationalization across the business. SG&A expenses for the quarter were $92 million, or 43% of revenue, versus $87 million in the second quarter, or 39%. The increase in SG&A expense is primarily driven by the acquisition of additional dispensaries and related staff, as well as a change in our long-term incentive program. We had a net loss of $43 million, driven by the items mentioned above. I'd also like to call out that we are still calculating our taxes as 280E filers, which, of course, greatly impacts our profitability. Lastly, Adjusted EBITDA for the quarter was $64 million, or 30% of revenue. Turning to the balance sheet and cash flows, we ended the quarter with $65 million in cash and cash equivalents, in line with expectations after incorporating our recent acquisition.
Cash flow from operations year to date was $69 million, and operating cash flow was $74 million for the same measure, as we have generally held working capital in check. Thus far, we've spent $85 million in CapEx, largely on Florida cultivation expansion and various dispensary openings. Looking ahead to the fourth quarter, we anticipate that the organic revenue trends of the third quarter will persist into the fourth quarter across most of our markets, offset somewhat by the year-end holiday lift, and now I'll hand it back to George to wrap up.
Thanks, Brett. We continue to look at the business through a growth lens. Ohio's launch marked our eighth adult use conversion, further strengthening our blueprint for success, one we look forward to implementing again in the future, and on top of the incredible growth some of our markets have yet to realize, we have a final rescheduling decision ahead of us. A reclassification to Schedule III should begin to bring some normalcy to the industry. We expect to realize many benefits from that final decision on top of being taxed as a normal company. I want to close today by reiterating that we remain very optimistic on the space. There has never been a time in American history when liberalizing cannabis policy was more visible to the American people. Who would have thought a Republican presidential candidate was actually running on a pro-cannabis platform?
December will see a preliminary ALJ hearing on rescheduling, a hearing on our constitutional challenge to the Controlled Substances Act, and the formation of an administration who we believe will be the best our industry has yet seen. We may get knocked down, but we always get back up again. No one is going to keep us down, and now, operator, please open up for questions.
Thank you. We are now opening the floor for question-and-answer session. If you'd like to ask a question, please press star one. Your first question comes from Aaron Grey from Alliance Global Partners. Your line is now open.
Hi, good morning, and thank you for the question. First question for me, just on Florida. Appreciate the color there in terms of starting to improve some of the trends from some issues you had had prior quarter that continued for Q3 too, but a bigger picture moving forward with Apollo and then kind of coming online and two-tier facilities you'd already implemented. Just how best to think about within the medical-only market now, the competitive dynamics? Do you feel like this gives you opportunity to still open more stores, even within the medical-only market? Or do you feel like you'll be able to put that supply through the existing stores? So just how do you believe the competitive dynamics are going to evolve within Florida, remaining a medical-only market for yourselves and for the broader market as well as other people have been expanding canopy? Thank you.
Hey, good morning, Aaron. Thank you for the question. As far as the supply, it was needed regardless, especially the Apollo Beach expansion. We're going to probably continue to add some stores, albeit probably more slowly than we would have a few days ago. But the medical market is still a very strong market in Florida. It's one of the best in the country. It's still one of our top markets here at Verano and for some other operators. I would assume that very few dollars will be spent in Florida going forward. So for us, that still makes it one of our top priorities. We have a nice pipeline of stores that will continue to open throughout the rest of the year and next year. And the expansion, again, it was needed. The third Apollo facility, beautiful facility, world-class. We obviously won't build out the entire facility now.
We'll do what we always have done in the past. It'll be a phased approach, and we'll bring it on as needed. The supply will be able to allow us to have more strains, more products. If pricing pressure is a thing in Florida, we'll be able to compete in a very big way. Efficiencies have been gained across the board in every SKU that we currently create in Florida. So it's onward and upward we go. Adult Use will come one day. We'll be better prepared for it, and it was a great week regardless. Seeing 56% of the vote, despite all the negative ads that were coming in from the DeSantis campaign, you still had quite a few voters turn out, and you saw that the cannabis is well-liked in Florida.
Sooner or later, they're going to have to pay attention to that, and hopefully, we get a legislative fix here in the next couple of years.
No, indeed. And I appreciate that commentary there. Second question for me, just in terms of the wholesale and more specifically on New Jersey. I know historically we've talked a lot about saturation on the retail in New Jersey, but wholesale down in the quarter. Brett, you made a comment in terms of third-party wholesale relationships being evaluated. So just want to clarify, was that more specific to New Jersey or more broadly speaking? And then if you could give commentary in terms of the competitive environment, specifically in New Jersey, and finding success on the retail shelves because it does look like it took a bit of a dip there in the quarter. Thank you.
Yeah, thanks for the question. So I think it's not just unique to New Jersey as it relates to this, right? The industry right now is going through a lot of challenges, and a lot of the smaller guys, in particular, even some of the larger ones, are just not able to manage their cash the way that they need to. And as a result, some people are starting to do late payments. We're seeing a lot of bad behavior in that regard, and we started cutting out customers. So we've been looking at our past dues. We've been asking for payment plans, that sort of thing, and making sure we have all of our ducks in a row on that. And as a result, we're cutting out customers and not shipping. So that's what you're seeing.
It's coming through our wholesale lines, our third-party wholesale lines, New Jersey, and other places as well.
Okay, great. Thank you very much for the commentary, and I'll jump back in the queue.
Thanks, Aaron.
Thanks.
Your next question comes from Russell Stanley from Beacon Securities. Your line is now open.
Good morning, and thank you for taking my question. Maybe if I could ask about Virginia, congrats on closing that. Looks like it'll be a great market. Wondering if you can elaborate on what your plans are. I think George had mentioned maybe a little CapEx plans, but we'd love to hear what you now have in store for that market. I think you talked about upgrading the grow and relocating a dispensary, but any color beyond that would be real helpful. Thanks.
Hey, good morning, Russ. Virginia was a great acquisition for us. We have a phenomenal team there. The current plan is to continue to introduce new products to the market. We're going to need to increase our vertical integration there. We've already launched a number of SKUs going extremely well, so we're seeing tick-ups in vertical integration week over week. We'll continue to introduce new products that aren't available in that market and all of the SKUs that made us successful throughout the country. So that's the current plan. The CapEx needed there is very minimal. There are small improvements that will be needed to increase efficiency on the grow side as well as on the processing side. But again, small improvements that'll give us greater big gains in efficiencies, and that's what we're doing, Russ.
Thanks on that. And maybe moving to Arizona following the closing of that transaction. Wondering what your plans now are in that market. How do you feel your balance between retail and cultivation? Are you happy with your footprint? Do you need more of either? And what your plans might be for the grow that you acquired? Thanks.
Good question. We're still assessing those plans in Arizona. We have three grows that are pretty spread out and additional processing. So we're looking at possibly consolidating some of those assets. On the retail front, always interested in more retail. It's a matter of price point and where it fits on the map. So Arizona might be a site for us for future growth. We do like the state. We like the vertical integration within those stores. We like the margins. It's a mature market. So there might be opportunities for us there in the future, and we'll continue to look.
Thanks. I'll get back in the queue.
Your next question comes from Nick Anderson from Roth MKM. Your line is now open.
Yeah, good morning. Thanks for taking the questions. First one for me is just on the consumer and the potential wallet pressure. Are you seeing any trading down, or is your premium category kind of holding up here? And have you seen any discernible shifts in consumer behavior worth calling out over the past couple of months here? Any color there would be helpful. Thank you.
Roughly the same. I mean, we've been seeing the trade down for some time now. So there's definitely pressure on the consumer wallet, but it's something we've been seeing. It's not something that just happened. It's been happening for us. So we've been pivoting. We've been focusing on our value lines and making sure that we have enough product there in that category because that seems, that's moving the most with the most velocity at the moment. So that's definitely a factor.
Okay, I appreciate that, Colin. Second one for me. Just wanted to get a little more color on the election and your take on Trump winning and just the potential roadmap for policy outside of rescheduling being passed? It sounds like he'll be a little more incrementally focused along with prioritizing some states' rights here, which may be better than looking for a comprehensive package. Just kind of your sense outside of rescheduling, the roadmap may be safer and some other policies being passed?
So from our perspective, and I'm going to let Darren opine as well, I think we're in a prime position to finally get some legislation done on the federal front. They have. It looks like they're going to have the House and the Senate, and Trump has been very positive on cannabis. So I think with the ALJ hearing and moving into 2025, I think we'll finally have some positive momentum and the ability for these guys to be able to act. I mean, we saw for the first time in our history both candidates talking about cannabis in a positive way, one talking about full legalization, one talking about states' rights. I think states' rights is obviously the way to go. Full legalization is an uphill battle, but we feel very positive about that momentum. Darren?
Yeah, no, thanks, George. So Nick, I definitely would echo George's comments. Our feeling is that taking a states' rights approach and an incremental approach is a much more reasonable path and one that's much more likely to lead to actual results. We've had enough, as I'm sure you can appreciate, of the platitudes on big broad changes. We're looking to get stuff done. And so we've had the opportunity to make inroads to the campaign and now to the transition team and are hearing lots of support both behind closed doors and, of course, publicly. So feeling really good. All efforts are going to be on legislative and executive action over the next near term for sure. But we're feeling really good about what the election at the top of the ticket has done for cannabis.
Great. That's good to hear. I appreciate the color. I'll jump back in the queue.
Your next question comes from Frederico Gomes from ATB Capital Markets. Your line is now open.
Hi, good morning. Thanks for taking my questions. First question on Ohio. Is there anything that surprised you or stood out in terms of differences in performance in each of your stores with the start of rec sales and as well as what kind of further increase to sales you think could happen in the state as new regulations in that market are implemented?
Good morning, Frederico. Ohio, as far as surprises go, we don't have a real adult use program here yet. There's multiple SKUs that aren't available to the consumer. We can't market. So it was a good jump. Obviously, we're very happy about it. That being said, we're still waiting for the adult use rules. We're still waiting for all these things that are lagging. So I think they're holding the market behind quite a bit. So we anticipate over the next few months for those rules to come out and be able to do more things that we do in other adult use markets, which should give us some additional ramp.
I don't want to guide on specific bump-ups, but when you don't have pre-rolls and you're not able to market to the consumer and do all of these things that we've done elsewhere, it does hold the market back a bit. So we'll see what's to come in 2025.
Thank you. And then my second question is on capital allocation. Specifically, I guess your buyback program. How are you seeing your valuation right now? Obviously, it's trading at all-time lows here given the sell-off in the space. So how should we think about your willingness to execute that buyback at current valuations and also considering all the other options that you have in terms of debt repayment, other growth initiatives, etc.?
We're always going to continue to look at our best options for our capital. That's obviously one of them that are available to us, and we'll continue to do that as we move forward.
Question comes from Matt Bottomley from Canaccord Genuity. Your line is now open.
Good morning, everyone. I'm just wondering if you can unpack your forward-looking commentary in the press release a little bit more with respect to the organic trends in Q3 expected to be the same in Q4. So you've given some good color on a state-by-state basis. So maybe I can piece this together with what's already been said. But if you kind of look at flat retail sales, wholesale sales down about 10% sequentially, and then in some of your bigger markets, we saw a little more volatility with the declines. Can you give any other color of what you expect to kind of reoccur? I know there was some additional weather you mentioned in Florida on the Hurricane Milton or anything specific that is to reoccur versus things that might be more one-time in the granular disclosures you guys gave.
Listen, it's hard to tell. October, we saw some of the similar trends, but as we get into the holiday season, usually we see a tick-up on the retail side. Wholesale, for us, it's going to be a little bit of a headwind. We have cut off a number of accounts across the country in multiple markets. So we'll see how that pans out for us. I don't want to give you specifics because if the customers don't catch up on their payments, then we're going to have to continue to cut them off, which is, for us, our motto is it's not a sale unless you collect the dollars on it. So we're taking that moving forward. So it's a short-term hit, but I believe in the long term, it's better for us as a company. So we'll see how that looks going forward.
But retail, I would anticipate to be flat, possibly up a little bit with the holiday sales coming up here, but we'll see how it plays out.
Okay, got it. And then just on that last comment you mentioned about the retail side of things, can you split that out a little bit more on the volume versus the price? We have had some of your peers talking during this earnings season about pricing pressures nationally. I think Pennsylvania was pointed out specifically, at least for the quarter. That could be one-off to that entity, but anything on the pricing side versus where you expect volumes to go?
As you've already heard from other operators, pricing pressure continues to be an issue in multiple markets in addition to more stores, etc. But like in Jersey and Illinois, it will come to a point where the market matures, everything's open, and things stabilize. It's just we're not there yet. So you see continued pricing pressures. Some of that scaling is occurring. So we'll see how it flattens out. In other markets where it's flattened out, it's great. We have a stable business. In others, we're still competing against that pricing pressure in the current opening. So I would anticipate somewhere in 2025 that that starts to flatten out even in Jersey and Illinois, but we'll see. We'll see.
I think with this week's results in Florida, it might wake some people up to not necessarily open up everything under the sun, right, and seeing the reality that running the business is not difficult, right, and you have to have scale and efficiency in order to be profitable and successful. So we'll see how it plays out in the next year.
Okay. Thanks, George.
Thanks, Matt.
If you'd like to ask a question, please press star one on your telephone keypad. Your next question comes from Andrew Semple from Ventum Capital Markets. Your line is now open.
Hi there. Good morning. Thanks for taking my question here. The first one would just maybe be more holistically on your CapEx plans for next year. Maybe what are some of the major projects you're looking at for 2025 or whether you're planning to maybe scale back CapEx pretty substantially next year? That would be helpful.
Hey, good morning, Andrew. Thanks for the question. As far as major CapEx, I mean, with Florida being basically shut down this week, no major CapEx needed for next year. There'll be some store refreshments, some minor adjustments, and some cultivation in oddball states, a handful of retail stores opening in certain markets, some automation, and some efficiency projects that we have going on, but we're talking about small dollars here compared to what we were doing. So we're back to cash flow and taking that cash flow and doing other things.
Got it. That's helpful. And then maybe in the prepared remarks, you mentioned renewed focus on costs and margins across the organization. Just wondering if you have maybe some early indications or if you could quantify kind of what you're seeing as the opportunity set out there for uncovering some of these cost efficiencies and optimizations across Verano.
I'm not going to guide the specific costs, but when you go from pedal-to-the-metal growth mode and then you go back to, let's stabilize, become efficient, there will be changes, right? so we were gearing up in a big way in Florida with manpower, CapEx, etc., and that's obviously not in front of us anymore, so we're going to have to scale back. We're going to cut some costs, and you'll see that over the next couple of quarters.
Got it. That's helpful. Thanks for taking my questions. I'll get back into queue.
Thank you.
That concludes our question-and-answer session. I'd now like to hand back over to George Archos for further remarks.
Thank you, everyone, for the continued support. I want to wish everyone a happy holidays and see you soon.
Thank you for attending today's call. You may now disconnect. Have a wonderful day, everyone.